Annual CFO
$138.29 M
-$8.49 M-5.78%
31 December 2023
Summary:
GoodRx Holdings annual cash flow from operations is currently $138.29 million, with the most recent change of -$8.49 million (-5.78%) on 31 December 2023. During the last 3 years, it has risen by +$6.95 million (+5.29%). GDRX annual CFO is now -22.65% below its all-time high of $178.78 million, reached on 31 December 2021.GDRX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$86.86 M
+$77.16 M+795.39%
30 September 2024
Summary:
GoodRx Holdings quarterly cash flow from operations is currently $86.86 million, with the most recent change of +$77.16 million (+795.39%) on 30 September 2024. Over the past year, it has increased by +$26.59 million (+44.12%). GDRX quarterly CFO is now at all-time high.GDRX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$155.02 M
+$26.59 M+20.71%
30 September 2024
Summary:
GoodRx Holdings TTM cash flow from operations is currently $155.02 million, with the most recent change of +$26.59 million (+20.71%) on 30 September 2024. Over the past year, it has increased by +$714.00 thousand (+0.46%). GDRX TTM CFO is now -13.66% below its all-time high of $179.54 million, reached on 30 June 2022.GDRX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDRX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.8% | +44.1% | +0.5% |
| 3 y3 years | +5.3% | +78.9% | +7.8% |
| 5 y5 years | +205.6% | - | - |
GDRX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -22.6% | +5.3% | at high | +795.4% | -13.7% | +21.3% |
| 5 y | 5 years | -22.6% | +205.6% | at high | +795.4% | -13.7% | +240.0% |
| alltime | all time | -22.6% | +205.6% | at high | +795.4% | -13.7% | +240.0% |
GoodRx Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $86.86 M(+795.4%) | $155.02 M(+20.7%) |
| June 2024 | - | $9.70 M(-77.2%) | $128.43 M(-13.6%) |
| Mar 2024 | - | $42.59 M(+168.4%) | $148.59 M(+7.4%) |
| Dec 2023 | $138.29 M(-5.8%) | $15.87 M(-73.7%) | $138.29 M(-10.4%) |
| Sept 2023 | - | $60.27 M(+101.8%) | $154.30 M(+20.8%) |
| June 2023 | - | $29.87 M(-7.5%) | $127.77 M(-14.2%) |
| Mar 2023 | - | $32.29 M(+1.3%) | $148.95 M(+1.5%) |
| Dec 2022 | $146.78 M | $31.88 M(-5.5%) | $146.78 M(-10.9%) |
| Sept 2022 | - | $33.73 M(-33.9%) | $164.71 M(-8.3%) |
| June 2022 | - | $51.05 M(+69.5%) | $179.54 M(+9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $30.12 M(-39.5%) | $163.41 M(-8.6%) |
| Dec 2021 | $178.78 M(+36.1%) | $49.81 M(+2.6%) | $178.78 M(+24.3%) |
| Sept 2021 | - | $48.56 M(+39.0%) | $143.82 M(+12.4%) |
| June 2021 | - | $34.93 M(-23.2%) | $127.93 M(-2.5%) |
| Mar 2021 | - | $45.48 M(+206.3%) | $131.23 M(-0.1%) |
| Dec 2020 | $131.34 M(+57.7%) | $14.85 M(-54.5%) | $131.34 M(+12.7%) |
| Sept 2020 | - | $32.67 M(-14.6%) | $116.49 M(+39.0%) |
| June 2020 | - | $38.23 M(-16.1%) | $83.83 M(+83.9%) |
| Mar 2020 | - | $45.59 M | $45.59 M |
| Dec 2019 | $83.29 M(+84.0%) | - | - |
| Dec 2018 | $45.25 M | - | - |
FAQ
- What is GoodRx Holdings annual cash flow from operations?
- What is the all time high annual CFO for GoodRx Holdings?
- What is GoodRx Holdings annual CFO year-on-year change?
- What is GoodRx Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for GoodRx Holdings?
- What is GoodRx Holdings quarterly CFO year-on-year change?
- What is GoodRx Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for GoodRx Holdings?
- What is GoodRx Holdings TTM CFO year-on-year change?
What is GoodRx Holdings annual cash flow from operations?
The current annual CFO of GDRX is $138.29 M
What is the all time high annual CFO for GoodRx Holdings?
GoodRx Holdings all-time high annual cash flow from operations is $178.78 M
What is GoodRx Holdings annual CFO year-on-year change?
Over the past year, GDRX annual cash flow from operations has changed by -$8.49 M (-5.78%)
What is GoodRx Holdings quarterly cash flow from operations?
The current quarterly CFO of GDRX is $86.86 M
What is the all time high quarterly CFO for GoodRx Holdings?
GoodRx Holdings all-time high quarterly cash flow from operations is $86.86 M
What is GoodRx Holdings quarterly CFO year-on-year change?
Over the past year, GDRX quarterly cash flow from operations has changed by +$26.59 M (+44.12%)
What is GoodRx Holdings TTM cash flow from operations?
The current TTM CFO of GDRX is $155.02 M
What is the all time high TTM CFO for GoodRx Holdings?
GoodRx Holdings all-time high TTM cash flow from operations is $179.54 M
What is GoodRx Holdings TTM CFO year-on-year change?
Over the past year, GDRX TTM cash flow from operations has changed by +$714.00 K (+0.46%)